Healthcare Industry Updates Live Cell Encapsulation Market | Emerging Trends | Page 4

The Live Cell Encapsulation Market is segmented into five major regions, namely, North
America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. North America is
estimated to be the largest regional market for live cell encapsulation in 2019 majorly due to the
increasing clinical data for the efficacy of the cell encapsulation technique and the rising adoption of cell
encapsulation techniques among medical professionals.
The major players operating in the live cell encapsulation market are BioTime, Inc. (US), Viacyte, Inc.
(US), and Living Cell Technologies Ltd. (Australia). Other prominent players operating in this market
include Sigilon Therapeutics, Inc. (US), Evonik Industries (Germany), BÜCHI Labortechnik AG (Germany),
Blacktrace Holdings Ltd (UK), and Sernova Corporation (Canada), among others. Furthermore, the key
players with developmental pipeline products in this market include Neurotech Pharmaceuticals, Inc.
(US), Gloriana Therapeutics (US), Kadimastem (Israel), Beta-O2 Technologies, Inc. (Israel), Defymed
(France), and Altucell, Inc. (US), among others